EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 28 / No 12 (Décembre 2012) Med Sci (Paris), 28 12 (2012) 1095-1101 References
Free Access
Issue
Med Sci (Paris)
Volume 28, Number 12, Décembre 2012
Page(s) 1095 - 1101
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20122812020
Published online 21 December 2012
  1. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001 ; 409 : 860–921. [CrossRef] [PubMed] [Google Scholar]
  2. Altshuler DM, Gibbs RA, Peltonen L, et al. Integrating common and rare genetic variation in diverse human populations. Nature 2010 ; 467 : 52–58. [CrossRef] [PubMed] [Google Scholar]
  3. Durbin RM, Abecasis GR, Altshuler DL, et al. A map of human genome variation from population-scale sequencing. Nature 2010 ; 467 : 1061–1073. [CrossRef] [PubMed] [Google Scholar]
  4. Barreiro LB, Laval G, Quach H, et al. Natural selection has driven population differentiation in modern humans. Nat Genet 2008 ; 40 : 340–345. [CrossRef] [PubMed] [Google Scholar]
  5. Casanova JL, Abel L. Inborn errors of immunity to infection: the rule rather than the exception. J Exp Med 2005 ; 202 : 197–201. [CrossRef] [PubMed] [Google Scholar]
  6. Barreiro LB, Quintana-Murci L. From evolutionary genetics to human immunology: how selection shapes host defence genes. Nat Rev Genet 2010 ; 11 : 17–30. [CrossRef] [PubMed] [Google Scholar]
  7. Quintana-Murci L, Alcais A, Abel L, Casanova JL. Immunology in natura: clinical, epidemiological and evolutionary genetics of infectious diseases. Nat Immunol 2007 ; 8 : 1165–1171. [CrossRef] [PubMed] [Google Scholar]
  8. Nielsen R, Hellmann I, Hubisz M, et al. Recent and ongoing selection in the human genome. Nat Rev Genet 2007 ; 8 : 857–868. [CrossRef] [PubMed] [Google Scholar]
  9. Sabeti PC, Schaffner SF, Fry B, et al. Positive natural selection in the human lineage. Science 2006 ; 312 : 1614–1620. [CrossRef] [PubMed] [Google Scholar]
  10. Delneste Y, Beauvillain C, Jeannin P. Immunité naturelle : structure et fonction des Toll-like receptors. Med Sci (Paris) 2007 ; 23 : 67–73. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  11. Barreiro LB, Ben-Ali M, Quach H, et al. Evolutionary dynamics of human Toll-like receptors, their different contributions to host defense. PLoS Genet 2009 ; 5 : e1000562. [CrossRef] [PubMed] [Google Scholar]
  12. Isaacs A, Lindenmann J. Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 1957 ; 147 : 258–267. [CrossRef] [PubMed] [Google Scholar]
  13. Pestka S, Krause CD, Walter MR. Interferons, interferon-like cytokines, and their receptors. Immunol Rev 2004 ; 202 : 8–32. [CrossRef] [PubMed] [Google Scholar]
  14. Uze G, Schreiber G, Piehler J, Pellegrini S. The receptor of the type I interferon family. Curr Top Microbiol Immunol 2007 ; 316 : 71–95. [CrossRef] [PubMed] [Google Scholar]
  15. Kotenko SV, Gallagher G, Baurin VV, et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 2003 ; 4 : 69–77. [CrossRef] [PubMed] [Google Scholar]
  16. Kotenko SV, Krause CD, Izotova LS, et al. Identification and functional characterization of a second chain of the interleukin-10 receptor complex. EMBO J 1997 ; 16 : 5894–5903. [CrossRef] [PubMed] [Google Scholar]
  17. Zhang SY, Boisson-Dupuis S, Chapgier A, et al. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense. Immunol Rev 2008 ; 226 : 29–40. [CrossRef] [PubMed] [Google Scholar]
  18. Filipe-Santos O, Bustamante J, Chapgier A, et al. Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol 2006 ; 18 : 347–361. [CrossRef] [PubMed] [Google Scholar]
  19. Chapgier A, Wynn RF, Jouanguy E, et al. Human complete Stat-1 deficiency is associated with defective type I and II IFN responses in vitro but immunity to some low virulence viruses in vivo. J Immunol 2006 ; 176 : 5078–5083. [PubMed] [Google Scholar]
  20. Ge D, Fellay J, Thompson AJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009 ; 461 : 399–401. [CrossRef] [PubMed] [Google Scholar]
  21. Thomas DL, Thio CL, Martin MP, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009 ; 461 : 798–801. [CrossRef] [PubMed] [Google Scholar]
  22. Labie D, Gilgenkrantz H. Variants génétiques du gène IL28B et élimination du virus de l’hépatite C. Med Sci (Paris) 2010 ; 26 : 225–226. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  23. Tanaka Y, Nishida N, Sugiyama M, et al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 2009 ; 41 : 1105–1109. [CrossRef] [PubMed] [Google Scholar]
  24. Manry J, Laval G, Patin E, et al. Evolutionary genetic dissection of human interferons. J Exp Med 2011 ; 208 : 2747–2759. [CrossRef] [PubMed] [Google Scholar]
  25. Genin P, Vaccaro A, Civas A. The role of differential expression of human interferon – a genes in antiviral immunity. Cytokine Growth Factor Rev 2009 ; 20 : 283–295. [CrossRef] [PubMed] [Google Scholar]
  26. Trinchieri G. Type I interferon: friend or foe?. J Exp Med 2010 ; 207 : 2053–2063. [CrossRef] [PubMed] [Google Scholar]
  27. Foster GR, Rodrigues O, Ghouze F, et al. Different relative activities of human cell-derived interferon-alpha subtypes: IFN-alpha 8 has very high antiviral potency. J Interferon Cytokine Res 1996 ; 16 : 1027–1033. [PubMed] [Google Scholar]
  28. Jaks E, Gavutis M, Uze G, et al. Differential receptor subunit affinities of type I interferons govern differential signal activation. J Mol Biol 2007 ; 366 : 525–539. [CrossRef] [PubMed] [Google Scholar]
  29. Lavoie TB, Kalie E, Crisafulli-Cabatu S, et al. Binding and activity of all human alpha interferon subtypes. Cytokine 2011 ; 56 : 282–289. [CrossRef] [PubMed] [Google Scholar]
  30. Coccia EM, Severa M, Giacomini E, et al. Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur J Immunol 2004 ; 34 : 796–805. [CrossRef] [PubMed] [Google Scholar]
  31. Genin P, Lin R, Hiscott J, Civas A. Differential regulation of human interferon A gene expression by interferon regulatory factors 3 and 7. Mol Cell Biol 2009 ; 29 : 3435–3450. [CrossRef] [PubMed] [Google Scholar]
  32. Manry J, Laval G, Patin E, et al. Evolutionary genetics evidence of an essential, nonredundant role of the IFN-gamma pathway in protective immunity. Hum Mutat 2011 ; 32 : 633–642. [CrossRef] [PubMed] [Google Scholar]
  33. O’Brien TR. Interferon-alfa, interferon-lambda and hepatitis C. Nat Genet 2009 ; 41 : 1048–1050. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.